IPOX® Global 50 Index (IPGL50)

The IPOX® Global 50 Index is an applied market-cap weighted index portfolio that measures the performance of the top 50 newly public companies globally. These companies are primarily selected through IPOs and spin-offs and are ranked quarterly by market cap in the IPOX® Global Composite Index, subject to stringent liquidity and exposure criteria. The IPOX® Global 50 Index has historically captured approximately 50% of the total market cap created through global IPO and spin-off activity.

View Fact Sheet

The Best of Super Liquid Global New Listings

The IPOX® Global 50 Index includes a diverse mix of firms representing recent global Equity Capital Markets (ECM) trends. The index is designed to provide exposure to the most liquid new listings, ensuring investors access to highly tradable and dynamic companies. This liquidity focus enhances the index's ability to reflect market conditions accurately and allows for efficient portfolio management. While the broader Index Universe covers all major world regions, providing broad exposure to high-potential markets, current members are mostly focused on listings in the U.S. and Europe, with significant representation from Asia as well.

High Liquidity Companies

The IPOX® Global 50 Index boasts holdings in some of the world's most liquid and high-performing newly public companies. Here are a few key examples:

Palantir Technologies: A leader in big data analytics software listed in the U.S., its shares reflect strong investor interest in data-driven solutions.
Mitsubishi UFJ Financial Group: One of Japan's largest financial institutions, demonstrating the significant role of established global banks undergoing strategic shifts or capital raises.
ARM Holdings: Listed in the U.S., this British semiconductor design leader's shares are highly traded, reflecting confidence in the tech sector's growth.
Samsara: Specializing in Internet of Things (IoT) solutions, this U.S.-listed firm has quickly become a favorite among investors, ensuring robust trading volumes.
UCB: This Belgian biopharmaceutical company focuses on immunology and neurology treatments. UCB's strong drug pipeline and market performance make its shares widely traded.
Sompo Holdings: A major Japanese insurance group, Sompo Holdings offers a range of services including non-life insurance, life insurance, and healthcare, driving strong investor interest.

For investors looking to capitalize on the liquidity and innovation of top-performing public companies, the IPOX® Global 50 Index provides an exceptional, all-in-one solution. Utilizing a rules-based methodology and quarterly rebalancing, this index is designed to systematically capture the performance of these highly tradable and dynamic firms.